Nadereh Behtash, Fariba Behnamfar, Bahareh Hamedi, Fatemeh Ramezanzadeh,
Tópico(s): Polyomavirus and related diseases
2008 - Springer Science+Business Media | Archives of Gynecology and Obstetrics
F. Ghaemmaghami, Nadereh Behtash, Fariba Yarandi, Azam Moosavi, M Modares, Gholamreza Toogeh, Navid Khanafshar,
This study was designed to assess the role of first-line chemotherapy with 5-fluorouracil (5-FU) and platinum in the treatment of advanced or recurrent cervical cancer. Ten patients with advanced or recurrent cancer of the cervix with no prior chemotherapy were entered in a phase II trial from October 2000 to November 2001. Eight patients were treated with Cis-platinum (50 mg/m2 over 60 minutes on the first day) followed by 5-FU (1 g/m2 over 24 hours for 4 days) and two patients with impaired renal ...
Tópico(s): Lymphoma Diagnosis and Treatment
2003 - Informa | Journal of Obstetrics and Gynaecology
Nadereh Behtash, Fatemeh Ghaemmaghami, Fariba Yarandi, Farid Azmoudeh Ardalan, Navid Khanafshar,
Background. Metastasis to the skin occurs rarely in gynecologic cancer, especially in cervical carcinoma. Although carcinoma of the cervix is the second to the fourth most common malignancy in women, cutaneous involvement originating from cervical cancer is particularly unusual, even in the terminal stage of the disease. Case. We present a case of cervical cancer recurrence with skin metastasis. The extensive skin lesion on the abdominal wall occurred 4 years after radical surgery and postoperative ...
Tópico(s): Genital Health and Disease
2002 - Elsevier BV | Gynecologic Oncology
M Modares Gilani, Mojgan Karimi‐Zarchi, Nadereh Behtash, F. Ghaemmaghami, A. Mousavi, Fariba Behnamfar,
To report a case of FIGO stage III papillary serous carcinoma of ovary, diagnosed during pregnancy at 20 weeks of gestation and treated with unilateral salpingo-oophorectomy and surgical staging, then initial combination chemotherapy while preserving the pregnancy. The patient underwent cesarean section at 35 weeks after four courses of taxol plus carboplatin. She delivered a healthy baby. After that total hysterectomy, omentectomy, pelvic and para-aortic lymphadenectomies were carried out. The ...
Tópico(s): Multiple and Secondary Primary Cancers
2007 - BMJ | International Journal of Gynecological Cancer
Fariba Behnamfar, M Modares Gilani, Nadereh Behtash, Fatemeh Ghaemmaghami, AzamS Moosavi, Elahe Rezayof,
Background: Gestational trophoblastic neoplasia (GTN) includes a spectrum of disease ranging from hydatidifrom mole to choriocarcinoma. Low risk GTN is defined as persistent molar pregnancy with a WHO score lower than seven. The optimal chemotherapeutic regimen still remains controversial. Aim: The objectives of this study was to determine efficacy and safety of weekly intramuscular methotrexte in the treatment of low risk gestational trophoblastic neoplasia.(LRGTN) and also identify prognostic factors ...
Tópico(s): Gestational Trophoblastic Disease Studies
2013 - BioMed Central | Journal of Cancer Research and Therapeutics
Nadereh Behtash, M Modares, Maryam Abolhasani, F. Ghaemmaghami, Maryam Mousavi, Fariba Yarandi, P. Hanjani,
Thirty-eight patients with ovarian tumours of low malignant potential (borderline) were diagnosed and treated in Tehran University Gynecology Oncology Department from 1991 to 2002, and have been reviewed. In this study age, clinical behavior, symptoms, surgical stage, type of tumour, surgery, adjuvant treatment, survival and recurrences were evaluated. A retrospective chart review was performed on these 38 patients who were treated for histopathologically confirmed tumours of low malignant potential ...
Tópico(s): Reproductive Biology and Fertility
2004 - Informa | Journal of Obstetrics and Gynaecology
Elham Shirali, Fariba Yarandi, Nadereh Behtash, Omid Hemmatian,
Tópico(s): Cervical Cancer and HPV Research
2018 - | Journal of Obstetrics Gynecology and Cancer Research
Ghaem Maghami Fatemeh, Nadereh Behtash, Fariba Yarandi, A. Mousavi, Tougeh Gh.R., Navid Khanafshar,
This study was designed to assess the role of first-line chemotherapy with 5-FU and platinum in the treatment of advanced or recurrent cervical cancer, ten patients with advanced or recurrent cancer of the cervix, with no prior chemotherapy were entered in phase II trial, from Oct. 2000 to Nov. 2001. Eight patients were treated with cis-platinum (50 mg/m2 over 60 minutes in first day) followed by 5-FU (1 g/m2 over 24 hours for 4 days) and two patients with impaired renal function were treated with ...
Tópico(s): Cervical Cancer and HPV Research
2003 - Tehran University of Medical Sciences | ACTA MEDICA IRANICA
Behnaz Moradi, Maryam Aghasi, Maryam Rahmani, Emile Sharifi, Mahrooz Malek, Fariba Yarandi, Masoumeh Banihashemian, Nadereh Behtash, Hamed Abdolghafoorian,
Tópico(s): Endometrial and Cervical Cancer Treatments
2025 - Colégio Brasileiro de Radiologia e Diagnóstico por Imagem | Radiologia Brasileira